Ayurveda Treatment of Brahmi Vati in Generalized Anxiety Disorder
Received Date: Mar 01, 2023 / Accepted Date: Mar 23, 2023 / Published Date: Mar 29, 2023
Abstract
Generalized Anxiety Disorder (GAD) is the foremost common anxiety disorder. GAD has tall comorbidities and it can influence social, proficient and individual life. Ayurvedic medicine, Brahmi vati is investigated for the possible role in management of GAD and is compared to Manasmitra vataka. A randomized double blind controlled trial, with total 56 patients meeting the DSM V criteria of GAD between 20–60 years of age and either sex participated within the study. Members were randomly partitioned into two groups, Brahmi group received capsule B. vati 500 mg and Manasmitra group received capsule M. vataka 500 mg thrice a day with water for 45 days. Assessments were conducted through different clinical parameters such as Hamilton Anxiety Rating Scale. Blood variables including Hemoglobin, Erythrocyte Sedimentation Rate (ESR), Liver Function Test (LFT) and serum creatinine were assessed before and after the study. Evaluations amid intervention were conducted on every 15th day. B. vati and M. vataka were effective, secure and comparable within the management of GAD.
Citation: Davies H (2023) Ayurveda Treatment of Brahmi Vati in Generalized Anxiety Disorder. J Tradit Med Clin Natur, 12: 376. Doi: 10.4172/2573-4555.1000376
Copyright: © 2023 Davies H. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Journals
Open Access Journals
Article Tools
Article Usage
- Total views: 738
- [From(publication date): 0-2023 - Aug 17, 2024]
- Breakdown by view type
- HTML page views: 668
- PDF downloads: 70